EX-4.10 4 dex410.htm EXCLUSIVE PROMOTION SERVICE EXCLUSIVE PROMOTION SERVICE AGREEMENT THIS AGREEMENT is made the 30th day of July 2007 betweenExclusive Promotion Service Agreement • May 5th, 2020
GLAXOSMITHKLINE (China) Investment Co., Ltd., whose registered office is at 9/F, Building A Ocean International Center, 56 Mid 4th East Ring Rd, Chao Yang District, Beijing (hereinafter referred to as “GSK”); and
EXCLUSIVE PROMOTION SERVICE AGREEMENT WITH KEXING BIOPHARM REGARDING CMAB008 (INFLIXIMAB)Exclusive Promotion Service Agreement • March 31st, 2022
This announcement is made by Mabpharm Limited (the “Company”, together with its subsidiaries, the “Group”) on a voluntary basis to inform the shareholders and potential investors of the Company about the latest business updates of the Group.
